MARK BARAVIK: Open Payments
NPI 1033547252 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,791 in 79 payments from 23 companies in 2025. Trend: 2023 $641 · 2024 $846 · 2025 $1,791
Food & beverage: $1,791
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $484 |
| Amgen Inc. | 14 | $180 |
| Lilly USA, LLC | 11 | $172 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $124 |
| Novo Nordisk Inc | 1 | $120 |
| Aimmune Therapeutics, Inc. | 5 | $112 |
| Exact Sciences Corporation | 4 | $96 |
| ABBVIE INC. | 4 | $95 |
| Sumitomo Pharma America, Inc. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
Products named: BREZTRI, AIRSUPRA, OTEZLA, Kerendia, ZENPEP, MOUNJARO, REXULTI, LINZESS.
Industry payments across CO — which companies pay providers there.
